C5AR1 and atypical hemolytic-uremic syndrome: Moreover, inhibitors of the C5a-C5aR axis could also find application in other situations when complement cascade is hyperactivated such as for example in Atypical Hemolytic Uremic Syndrome (aHUS) [30].